feed,title,long_url,short_url
Benzinga,"Argenx's Autoimmune Trial Stumble: Analysts Cut Price Targets, Warn of Risky Outcomes",https://benzinga.com/analyst-ratings/analyst-color/23/12/36347419/argenxs-autoimmune-trial-stumble-analysts-cut-price-targets-warn-of-risky-outcomes,https://da.gd/MoAhY
